Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Pathogenesis and Immunity

Second-Site Revertants of a Semliki Forest Virus Fusion-Block Mutation Reveal the Dynamics of a Class II Membrane Fusion Protein

Chantal Chanel-Vos, Margaret Kielian
Chantal Chanel-Vos
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Kielian
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kielian@aecom.yu.edu
DOI: 10.1128/JVI.00167-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Locations of second-site revertants of the H230A mutant in the E1*HT structure. Two of the three chains of the E1*HT (PDB entry 1RER) are represented in light gray, and the third chain is color-coded as follows: domain I in red, the first elongation of domain II in orange with the fusion loop at the tip, the second elongation of domain II in yellow with the cd loop at the tip, the linker between domains I and III in purple, domain III in blue, and the N-terminal portion of the stem present in the structure in black. Histidine 230 is represented as a red stick structure. Second-site mutations are represented by their van der Waals volumes and are color-coded as follows: the srf mutations in cyan (the srf-4 mutation on the a β-strand, the srf-5 mutation on the f β-strand, and the srf-3 mutation in the ij loop), the T70A mutation (bc loop, shown on two E1 chains) and its accompanying F200L mutation (gh loop) in green, the T234R mutation (j β-strand) in pink, the G83D mutation (fusion loop) in brown, and the three mutations found in combination at 37°C (the S120Y, Q187L, and M228I mutations, on the e and g β-strands and in the ij loop, respectively) in violet-blue. Note that the S120P and Q187L mutations were also found as single second-site mutations at 28°C (Table 1). This figure was prepared using PyMOL (6).

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Virus growth kinetics in BHK cells. BHK cells were infected with the pseudorevertants, H230A-srf3, or wt virus at a multiplicity of infection of 0.01 infectious centers (IC)/cell and incubated at 28°C (A) or 37°C (B) for the indicated times. At each time point, the culture media were collected and the progeny virus titers were determined by infectious center assay at 28°C (A) or plaque assay at 37°C (B). A representative example of two experiments is shown.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Formation and stability of wt and mutant E1 homotrimers. 35S-labeled wt (a), H230A-srf3 mutant (b), H230A-srf4 mutant (c), and H230A-srf5 mutant (d) viruses were mixed with liposomes and treated at pH 8.0 (lanes 1 and 3) or at pH 5.5 (lanes 2, 4, and 5). The SDS resistance of the E1HT was assessed by solubilization in SDS sample buffer for 3 min at 30°C followed by SDS-PAGE (lanes 1 and 2). The trypsin resistance of the E1HT was determined by trypsin digestion (lanes 3 and 5) followed by trichloroacetic acid precipitation and detection by SDS-PAGE. Control samples (lane 4) were digested in the presence of soybean trypsin inhibitor. The positions of E1HT, E2, and E1 are indicated. A representative example of three assays of each mutant is shown.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Cholesterol requirements of wt and mutant SFV infection. Control (black bars) and cholesterol-depleted (hatched or white bars) C6/36 mosquito cells were infected with serial dilutions of the indicated virus stocks. The cells were then incubated overnight in the presence of NH4Cl to prevent secondary infection, and infected cells were quantitated by immunofluorescence. The infectivity of each virus on control cells was normalized to 1 × 106 infectious centers (IC)/ml (27). Data shown are averages of two determinations with the range indicated. The hatched bars indicate mutants with a cholesterol dependence significantly lower than that of wt SFV, and the white bars indicate the wt SFV and those mutants with a significantly higher cholesterol dependence.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Proposed model for the action of the second-site revertants of the E1 H230A mutant. The suggested mechanism for each group of revertants is illustrated using the surface representation of the SFV E1*HT structure with one monomer color-coded as in Fig. 1. The missing portion of the stem and the TM domain are represented by light-blue and dark-gray cylinders, respectively. The H230A mutation is shown in pink towards the tip of the yellow region of domain II. The second-site mutations are indicated in dark blue in each panel. (A) The hinge mutations act to change the angle of the hinge, as shown by the angled black arrow in which the angle position approximates the distance of the mutations from the domain II tip. Only the srf-4 mutation is visible on the external trimer surface. (B) The G83D mutation acts via charge repulsion to splay apart the domain II tips, as indicated by the short black arrows. (C) The T234R mutation acts to promote the packing of the stem within the groove of the H230A mutant trimer, as indicated by the arrow on the stem.

Tables

  • Figures
  • TABLE 1.

    Pseudorevertants of the H230A mutant

    Selection temp (°C)Second-site mutationaChange in nucleotide sequencebNo. of independent isolates
    28G83DGGC → GAC1
    L44FTTG → TTT2
    V178AGTC → GCC5
    S120PTCT → CCT1
    Q187LCAG → CTG2
    T70AACT → GCT
    F200LTTC → TTG1
    37Q187LCAG → CTG
    S120YTCT → TAT1
    M228IATG → ATA
    T234RACA → AGA1
    • ↵ a Shown are second-site mutations present in addition to the H230A mutation in the pseudorevertants. L44F is the same amino acid change found in the srf-4 mutant, and V178A is the same amino acid change found in the srf-5 mutant.

    • ↵ b Nucleotide changes found in the pseudorevertants are highlighted in bold.

PreviousNext
Back to top
Download PDF
Citation Tools
Second-Site Revertants of a Semliki Forest Virus Fusion-Block Mutation Reveal the Dynamics of a Class II Membrane Fusion Protein
Chantal Chanel-Vos, Margaret Kielian
Journal of Virology May 2006, 80 (12) 6115-6122; DOI: 10.1128/JVI.00167-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Second-Site Revertants of a Semliki Forest Virus Fusion-Block Mutation Reveal the Dynamics of a Class II Membrane Fusion Protein
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Second-Site Revertants of a Semliki Forest Virus Fusion-Block Mutation Reveal the Dynamics of a Class II Membrane Fusion Protein
Chantal Chanel-Vos, Margaret Kielian
Journal of Virology May 2006, 80 (12) 6115-6122; DOI: 10.1128/JVI.00167-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

membrane fusion
Membrane Fusion Proteins
Semliki Forest virus

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514